Publications by authors named "Meredith Mistark"

Claim this Profile
S
Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.
Vaishali Sanchorawala, Shayna Sarosiek, Amanda Schulman, Meredith Mistark, Mary Ellen Migre

Bloodยท April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis